Risk of liver cancer among US male veterans with cirrhosis, 1969-1996

British Journal of Cancer

Volumn 107, Issue 1, 2012, Pages 195-200

  Persson, E C ^a   Quraishi, S M ^a   Welzel, T M ^b   Carreon, J D ^a   Gridley, G ^a   Graubard, B I ^a   McGlynn, K A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

cirrhosis; cohort; epidemiology; Iver cancer; US Veterans Affairs

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DIABETES MELLITUS; HAZARD RATIO; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; UNITED STATES; VETERAN; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK; TIME FACTORS; UNITED STATES; VETERANS; YOUNG ADULT;

EID: 84862979356     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.193     Document Type: Article

References (29)

1. Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM (2000) Are patients at veterans affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 160(21): 3252-3257
2. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9): 1485-1491
3. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J (2010) Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 116(5): 1367-1377
4. Ashton CM, Petersen NJ, Wray NP, Yu HJ (1998) The Veterans Affairs medical care system: hospital and clinic utilization statistics for 1994. Med Care 36(6): 793-803 (Pubitemid 128454316)
5. Bialecki ES, Di Bisceglie AM (2005) Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17(5): 485-489 (Pubitemid 40592704)
6. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La VC (2007) Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46(5): 827-839 (Pubitemid 46529045)
7. Davila JA, El-Serag HB (2006) Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol 4(1): 104-110 (Pubitemid 43129531)
8. Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, El-Serag HB (2011) Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 154(2): 85-93
9. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB (2010) Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 52(1): 132-141
10. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127(5): 1372-1380 (Pubitemid 39457763)
11. Deswal A, Petersen NJ, Souchek J, Ashton CM, Wray NP (2004) Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 43(5): 778-784 (Pubitemid 38296475)
12. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126(2): 460-468 (Pubitemid 38182303)
13. Giordano TP, Morgan RO, Kramer JR, Hartman C, Richardson P, White Jr CA, Suarez-Almazor ME, El-Serag HB (2006) Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med 21(6): 613-617 (Pubitemid 43801491)
14. Grattagliano I, Ubaldi E, Bonfrate L, Portincasa P (2011) Management of liver cirrhosis between primary care and specialists. World J Gastroenterol 17(18): 2273-2282
15. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M (1990) Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99(5): 1401-1407 (Pubitemid 20381877)
16. Hoefs JC, Runyon BA (1985) Spontaneous bacterial peritonitis. Dis Mon 31(9): 1-48
17. Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, Richardson P, El-Serag HB (2011) Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 140(4): 1182-1188
18. Morgan TR, Mandayam S, Jamal MM (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1): S87-S96 (Pubitemid 39423374)
19. National Center for Health Statistics (US). Health, United States (2009) With Special Feature on Medical Technology. 2010-1232. 2010. National Center for Health Statistics (US): Hyattsville (MD)
20. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37(5): 1202-1219 (Pubitemid 36538699)
21. Page WF, Mahan CM, Kang HK (1996) Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 6(2): 102-109 (Pubitemid 26097394)
22. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D (1991) Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 324(22): 1532-1538
23. Randall M, Kilpatrick KE, Pendergast JF, Jones KR, Vogel WB (1987) Differences in patient characteristics between veterans administration and community hospitals. Implications for VA planning. Med Care 25(11): 1099-1104 (Pubitemid 17167569)
24. Rossle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W, Blum HE (1997) Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349(9058): 1043-1049 (Pubitemid 27158248)
25. Sabba C, Weltin GG, Cicchetti DV, Ferraioli G, Taylor KJ, Nakamura T, Moriyasu F, Groszmann RJ (1990) Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology 98(6): 1603-1611 (Pubitemid 20158628)
26. Schutte K, Bornschein J, Malfertheiner P (2009) Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 27(2): 80-92
27. Sharara AI, Rockey DC (2001) Gastroesophageal variceal hemorrhage. N Engl J Med 345(9): 669-681
28. The Veterans Affairs Cooperative Variceal Sclerotherapy Group (1991) Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med 324(25): 1779-1784
29. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA (2011) Metabolic syndrome increases the risk of primary liver cancer in the United States: A population-based case-control study. Hepatology 54(2): 463-471